CN101810745B - Plaster for treating hyperplasia of mammary glands - Google Patents
Plaster for treating hyperplasia of mammary glands Download PDFInfo
- Publication number
- CN101810745B CN101810745B CN2010101383563A CN201010138356A CN101810745B CN 101810745 B CN101810745 B CN 101810745B CN 2010101383563 A CN2010101383563 A CN 2010101383563A CN 201010138356 A CN201010138356 A CN 201010138356A CN 101810745 B CN101810745 B CN 101810745B
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- parts
- plaster
- cortex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000011505 plaster Substances 0.000 title claims abstract description 23
- 210000005075 mammary gland Anatomy 0.000 title abstract description 7
- 206010020718 hyperplasia Diseases 0.000 title abstract 3
- 239000003814 drug Substances 0.000 claims abstract description 35
- 229910052573 porcelain Inorganic materials 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 5
- 238000003756 stirring Methods 0.000 claims abstract description 4
- 238000002791 soaking Methods 0.000 claims abstract 4
- 239000000843 powder Substances 0.000 claims description 29
- 150000002333 glycines Chemical class 0.000 claims description 25
- 239000009636 Huang Qi Substances 0.000 claims description 23
- 238000011282 treatment Methods 0.000 claims description 21
- 239000003053 toxin Substances 0.000 claims description 4
- 241000322338 Loeseliastrum Species 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims 9
- 230000000694 effects Effects 0.000 abstract description 18
- 208000002193 Pain Diseases 0.000 abstract description 11
- 230000036407 pain Effects 0.000 abstract description 11
- 239000008280 blood Substances 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 8
- 239000000203 mixture Substances 0.000 abstract description 6
- 238000002360 preparation method Methods 0.000 abstract description 6
- 230000001105 regulatory effect Effects 0.000 abstract description 5
- 239000004744 fabric Substances 0.000 abstract description 2
- 210000004185 liver Anatomy 0.000 abstract description 2
- 229920002472 Starch Polymers 0.000 abstract 2
- 239000011324 bead Substances 0.000 abstract 2
- 239000003921 oil Substances 0.000 abstract 2
- 235000019198 oils Nutrition 0.000 abstract 2
- 235000012424 soybean oil Nutrition 0.000 abstract 2
- 239000003549 soybean oil Substances 0.000 abstract 2
- 235000019698 starch Nutrition 0.000 abstract 2
- 239000008107 starch Substances 0.000 abstract 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 241000533849 Gleditsia Species 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 241001673966 Magnolia officinalis Species 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000035508 accumulation Effects 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 206010016629 fibroma Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000001794 hormone therapy Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000004922 lacquer Substances 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000027758 ovulation cycle Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000003200 Adenoma Diseases 0.000 description 1
- 206010001233 Adenoma benign Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a plaster for treating hyperplasia of mammary glands, and belongs to a pure Chinese medicinal preparation. The plaster comprises the following components in part by weight: 4 to 8 parts of astragalus, 1 to 5 parts of largehead atractylodes rhizome, 1 to 5 parts of gleditsia thorn, 1 to 5 parts of pinellia tuber, 1 to 6 parts of officinal magnolia bark, 1 to 5 parts of Chinese angelica, 1 to 5 parts of cassia bark, 1 to 5 parts of nutgrass galingale rhizome, 1 to 5 parts of costustoot, 1 to 5 parts of raw rehmannia root, 1 to 5 parts of rhubarb, 1 to 5 parts of root ofred-rooted salvia, 1 to 5 parts of bitter orange, 1 to 5 parts of liquoric root, 400 to 600 parts of pure soybean oil and an appropriate amount of starch. A method for preparing the plaster comprises the following steps of: soaking the medicaments into the pure soybean oil; putting the medicaments into a sandy pot after soaking for enough days; decocting the medicaments over slow fire until the medicaments are dried and floated; filtering gruffs off with disinfected white cloth to prepare medicinal oil; making the ratio of the medicinal oil to the starch be 2:1; decocting the mixture over slow fire; continuously stirring the mixture until the mixture becomes sticky; dropping the mixture into water to become beads; collecting the beads into a porcelain container; and soaking the porcelain container into cold water for later use. The plaster has the effects of soothing liver and relieving depression, regulating vital energy and relieving pain, freeing network vessels and diminishing inflammation, and activating blood to dissipate stagnation because of compatibility of all the Chinese medicaments, and has obvious curative effect of treating the hyperplasia of mammary glands and over 80 percent of cure rate.
Description
Technical field
The present invention relates to a kind of external Chinese medicine, exactly is a kind of plaster of treating cyclomastopathy and mammary gland tumor, belongs to Chinese medicine preparation and applied technical field.
Background technology
Cyclomastopathy is common gynecological disease, see disease more.The method of treatment cyclomastopathy is main with Drug therapy mainly at present, and doctor trained in Western medicine adopts hormone therapy, but the hormone therapy cycle is long, and relapse rate is high, and side effect is big; Domestic many employing treatments by Chinese herbs, but curative effect is not ideal enough again.
Summary of the invention
The objective of the invention is deficiency, and a kind of plaster with treatment cyclomastopathy of dispersing the stagnated live-QI to relieve the stagnation of QI and transforming phlegm and dispersing accumulations effect is provided to above-mentioned prior art.This product belongs to pure Chinese medicinal preparation, and it is to carry out the drug osmotic treatment through skin surface.It contains following Chinese medicine ingredients: the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Spina Gleditsiae, the Rhizoma Pinelliae, Cortex Magnoliae Officinalis, Radix Angelicae Sinensis, Cortex cinnamomi japonici (Ramulus Cinnamomi), Rhizoma Cyperi, the Radix Aucklandiae, Radix Rehmanniae, Radix Et Rhizoma Rhei, Radix Salviae Miltiorrhizae, Fructus Aurantii, Radix Glycyrrhizae and true yellow Oleum Glycines and decide powder.Above-mentioned each composition weight share preparation: Radix Astragali 4-8; Rhizoma Atractylodis Macrocephalae 1-5; Spina Gleditsiae 1-5; Rhizoma Pinelliae 1-5; Cortex Magnoliae Officinalis 1-6; Radix Angelicae Sinensis 1-5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 1-5; Rhizoma Cyperi 1-5; Radix Aucklandiae 1-5; Radix Rehmanniae 1-5; Radix Et Rhizoma Rhei 1-5; Radix Salviae Miltiorrhizae 1-5; Fructus Aurantii 1-5; Radix Glycyrrhizae 1-5 and true yellow Oleum Glycines 400-600 are with to decide powder an amount of.
Above-mentioned Chinese medicine is made as follows: with true yellow Oleum Glycines medicine is soaked in the oil, soak time is 5 days springs, 3 days summers, 5 days autumns, 10 days winters.Wait to soak day full after, put it in the black earth pot, slow fire endures that to make medicine withered, floats to medicine, filters gruffs with the sterilization calico then, makes medicine oil.To going into to decide powder, the slow fire of useing force boils with medicine oil, and ceaselessly stirs with Ramulus Persicae, Ramulus Salicis Babylonicae, Ramulus Mori or Rumalus sophorae, treats that plaster like China ink as lacquer, splashes into Cheng Zhu in the water, takes in the porcelain then, and porcelain is put into cold water, soaks seven days, and releasing fire-toxin is subsequent use.
The present invention has significant curative effect for the treatment cyclomastopathy, and it adds the Radix Astragali with invigorating QI to consolidate the body surface resistance, expelling pus and toxin by strengthening QI, diuresis, granulation promoting in prescription; Have spleen reinforcing, stomach reinforcing, dampness and in, the dehumidifying benefit is dry, the Rhizoma Atractylodis Macrocephalae that quenches the thirst; Have and return liver, stomach through, evacuation of pus and the promoting blood circulation and detumescence effect of drawing out pus by applying a plaster to the affected part and be used for that carbuncle, sore, pus become to burst, the Spina Gleditsiae of scabies; The Rhizoma Pinelliae with drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass and externally used detumescence analgesic effect; Have dampness expectorant, the therapeutic method to keep the adverse QI flowing downwards except that full Cortex Magnoliae Officinalis; Have benefiting blood and regulating blood circulation, moisturize that laxation 、 mass in the abdomen knot gathers, metrorrhagia, headache due to deficiency of blood, dizzy, flaccidity syndrome and arthralgia syndrome, dryness of the intestine dyschezia, the carbuncle skin ulcer is stolen and the Radix Angelicae Sinensis of traumatic injury effect; Have warming the spleen and stomach, dispersing wind and cold, promoting blood circulation effect and, rheumatic arthralgia dysphagic, fall and decrease the stasis of blood and stagnate the Cortex cinnamomi japonici (Ramulus Cinnamomi) of significant curative effect is arranged vomitting; Has liver-smoothing, qi-regulating, the Rhizoma Cyperi of menstruction regulating and pain relieving; Have promoting the circulation of QI to relieve pain, strengthening the spleen to promote digestion effect, be mainly used in heavy behind breast gastral cavity distending pain, the dysentery, food stagnation does not disappear, the Radix Aucklandiae of anorexia; Have clearing away heat and cooling blood, YIN nourishing and the production of body fluid promoting effect, cure mainly that YIN damaged by pathogenic heat, crimson tongue excessive thirst, interior-heat caused by deficiency of YIN, night fever abating at dawn, hectic fever due to YIN-deficiency consumptive fever, interior-heat are quenched one's thirst, the Radix Rehmanniae of hematemesis and epistaxis and maculopapulae due to toxic heat; Has stimulate the menstrual flow effect and be used for the Radix Et Rhizoma Rhei of traumatic injury, swelling and pain due to blood stasis, removing damp-heat, cooling blood for hemostasis of removing toxicity for eliminating carbuncles, clots absorbing; Has the Radix Salviae Miltiorrhizae that promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle and relieving restlessness are calmed the nerves; Have regulating the flow of QI to ease the stomach, the stagnant relieving distension effect of row also is used for the breast side of body stagnation of QI, distension pain, the Fructus Aurantii of accumulation of food in the stomach and intes tine due to indigestion and the Radix Glycyrrhizae with invigorating the spleen and replenishing QI, expelling phlegm for arresting cough, relieving spasm to stop pain, heat-clearing and toxic substances removing and coordinating the actions of various ingredients in a prescription effect.Also added have removing food stagnancy, parasite killing, detoxifcation and granulation promoting effect decide powder.
The present invention is a pure Chinese medicinal preparation, because the compatibility effect of each flavor Chinese medicine has the effect of dispersing the stagnated live-QI to relieve the stagnation of QI, regulating QI to relieve pain, collateral dredging antiinflammatory and blood circulation promoting and dispersing pathogen accumulation, the treatment cyclomastopathy is evident in efficacy.The present invention can directly be affixed on the affected part, the medicine sick institute that goes directly.Its advantage is: efficacy consolidation, drug effect is fast, treatment cycle is short, have no side effect, that medical expense reaches method for preparing less is simple and easy to use.Can treat and effect a radical cure cyclomastopathy effectively, its cure rate can reach more than 80%.
The specific embodiment
Embodiment 1
Present embodiment comprises: the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Spina Gleditsiae, the Rhizoma Pinelliae, Cortex Magnoliae Officinalis, Radix Angelicae Sinensis, Cortex cinnamomi japonici (Ramulus Cinnamomi), Rhizoma Cyperi, the Radix Aucklandiae, Radix Rehmanniae, Radix Et Rhizoma Rhei, Radix Salviae Miltiorrhizae, Fructus Aurantii, Radix Glycyrrhizae and true yellow Oleum Glycines and decide powder.Above-mentioned each composition weight share preparation: Radix Astragali 4-8; Rhizoma Atractylodis Macrocephalae 1-5; Spina Gleditsiae 1-5; Rhizoma Pinelliae 1-5; Cortex Magnoliae Officinalis 1-6; Radix Angelicae Sinensis 1-5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 1-5; Rhizoma Cyperi 1-5; Radix Aucklandiae 1-5; Radix Rehmanniae 1-5; Radix Et Rhizoma Rhei 1-5; Radix Salviae Miltiorrhizae 1-5; Fructus Aurantii 1-5; Radix Glycyrrhizae 1-5 and true yellow Oleum Glycines 400-600 are with to decide powder an amount of.
Embodiment 2
Weight share is got Radix Astragali 4-4.5; Rhizoma Atractylodis Macrocephalae 1-1.5; Spina Gleditsiae 1-1.5; Rhizoma Pinelliae 1-1.5; Cortex Magnoliae Officinalis 1-1.5; Radix Angelicae Sinensis 1-1.5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 1-1.5; Rhizoma Cyperi 1-1.5; Radix Aucklandiae 1-1.5; Radix Rehmanniae 1-1.5; Radix Et Rhizoma Rhei 1-1.5; Radix Salviae Miltiorrhizae 1-1.5; Fructus Aurantii 1-1.5; Radix Glycyrrhizae 1-1.5 and true yellow Oleum Glycines 400 is with to decide powder an amount of.
Embodiment 3
Weight share is got Radix Astragali 4.5-5; Rhizoma Atractylodis Macrocephalae 1.5-2; Spina Gleditsiae 1.5-2; Rhizoma Pinelliae 1.5-2; Cortex Magnoliae Officinalis 1.5-2; Radix Angelicae Sinensis 1.5-2; Cortex cinnamomi japonici (Ramulus Cinnamomi) 1.5-2; Rhizoma Cyperi 1.5-2; Radix Aucklandiae 1.5-2; Radix Rehmanniae 1.5-2; Radix Et Rhizoma Rhei 1.5-2; Radix Salviae Miltiorrhizae 1.5-2; Fructus Aurantii 1.5-2; Radix Glycyrrhizae 1.5-2 and true yellow Oleum Glycines 500 is with to decide powder an amount of.
Embodiment 4
Weight share is got Radix Astragali 5-5.5; Rhizoma Atractylodis Macrocephalae 2-2.5; Spina Gleditsiae 2-2.5; Rhizoma Pinelliae 2-2.5; Cortex Magnoliae Officinalis 2-2.5; Radix Angelicae Sinensis 2-2.5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 2-2.5; Rhizoma Cyperi 2-2.5; Radix Aucklandiae 2-2.5; Radix Rehmanniae 2-2.5; Radix Et Rhizoma Rhei 2-2.5; Radix Salviae Miltiorrhizae 2-2.5; Fructus Aurantii 2-2.5; Radix Glycyrrhizae 2-2.5 and true yellow Oleum Glycines 500 is with to decide powder an amount of.
Embodiment 5
Weight share is got Radix Astragali 5.5-6; Rhizoma Atractylodis Macrocephalae 2.5-3; Spina Gleditsiae 2.5-3; Rhizoma Pinelliae 2.5-3; Cortex Magnoliae Officinalis 2.5-3; Radix Angelicae Sinensis 2.5-3; Cortex cinnamomi japonici (Ramulus Cinnamomi) 2.5-3; Rhizoma Cyperi 2.5-3; Radix Aucklandiae 2.5-3; Radix Rehmanniae 2.5-3; Radix Et Rhizoma Rhei 2.5-3; Radix Salviae Miltiorrhizae 2.5-3; Fructus Aurantii 2.5-3; Radix Glycyrrhizae 2.5-3 and true yellow Oleum Glycines 500 is with to decide powder an amount of.
Embodiment 6
Weight share is got Radix Astragali 6-6.5; Rhizoma Atractylodis Macrocephalae 3-3.5; Spina Gleditsiae 3-3.5; Rhizoma Pinelliae 3-3.5; Cortex Magnoliae Officinalis 3-3.5; Radix Angelicae Sinensis 3-3.5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 3-3.5; Rhizoma Cyperi 3-3.5; Radix Aucklandiae 3-3.5; Radix Rehmanniae 3-3.5; Radix Et Rhizoma Rhei 3-3.5; Radix Salviae Miltiorrhizae 3-3.5; Fructus Aurantii 3-3.5; Radix Glycyrrhizae 3-3.5 and true yellow Oleum Glycines 550 is with to decide powder an amount of.
Embodiment 7
Weight share is got Radix Astragali 6.5-7; Rhizoma Atractylodis Macrocephalae 3.5-4; Spina Gleditsiae 3.5-4; Rhizoma Pinelliae 3.5-4; Cortex Magnoliae Officinalis 3.5-4; Radix Angelicae Sinensis 3.5-4; Cortex cinnamomi japonici (Ramulus Cinnamomi) 3.5-4; Rhizoma Cyperi 3.5-4; Radix Aucklandiae 3.5-4; Radix Rehmanniae 3.5-4; Radix Et Rhizoma Rhei 3.5-4; Radix Salviae Miltiorrhizae 3.5-4; Fructus Aurantii 3.5-4; Radix Glycyrrhizae 3.5-4 and true yellow Oleum Glycines 550 is with to decide powder an amount of.
Embodiment 8
Weight share is got Radix Astragali 7-7.5; Rhizoma Atractylodis Macrocephalae 4-4.5; Spina Gleditsiae 4-4.5; Rhizoma Pinelliae 4-4.5; Cortex Magnoliae Officinalis 4-4.5; Radix Angelicae Sinensis 4-4.5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 4-4.5; Rhizoma Cyperi 4-4.5; Radix Aucklandiae 4-4.5; Radix Rehmanniae 4-4.5; Radix Et Rhizoma Rhei 4-4.5; Radix Salviae Miltiorrhizae 4-4.5; Fructus Aurantii 4-4.5; Radix Glycyrrhizae 4-4.5 and true yellow Oleum Glycines 550 is with to decide powder an amount of.
Embodiment 9
Weight share is got Radix Astragali 7.5-8; Rhizoma Atractylodis Macrocephalae 4.5-5; Spina Gleditsiae 4.5-5; Rhizoma Pinelliae 4.5-5; Cortex Magnoliae Officinalis 4.5-5; Radix Angelicae Sinensis 4.5-5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 4.5-5; Rhizoma Cyperi 4.5-5; Radix Aucklandiae 4.5-5; Radix Rehmanniae 4.5-5; Radix Et Rhizoma Rhei 4.5-5; Radix Salviae Miltiorrhizae 4.5-5; Fructus Aurantii 4.5-5; Radix Glycyrrhizae 4-4.5 and true yellow Oleum Glycines 550 is with to decide powder an amount of.
Embodiment 10
Get Radix Astragali 30g; Each 15g of the Rhizoma Atractylodis Macrocephalae, Spina Gleditsiae, the Rhizoma Pinelliae, Cortex Magnoliae Officinalis, Radix Angelicae Sinensis, Cortex cinnamomi japonici (Ramulus Cinnamomi), Rhizoma Cyperi, the Radix Aucklandiae, Radix Rehmanniae, Radix Et Rhizoma Rhei, Radix Salviae Miltiorrhizae, Fructus Aurantii and Radix Glycyrrhizae; True yellow Oleum Glycines 2500g is with to decide powder an amount of.
Make the plaster like the described treatment cyclomastopathy of embodiment 1-10, its manufacture method is described below:
To make as follows by the Chinese medicine of above-mentioned weight proportion: with true yellow Oleum Glycines medicine is soaked in the oil, soak time is 5 days springs, 3 days summers, 5 days autumns, 10 days winters.Wait to soak day full after, put it in the black earth pot, slow fire endure do medicine withered (with medicine endure withered), float to medicine, filter gruffs with the sterilization calico then, make medicine oil.To going into to decide powder 500g (deciding powder can substitute with Plumbum preparatium), promptly medicine oil is 2: 1 with the ratio of deciding powder with the every 1000g of medicine oil, and the slow fire of useing force boiled 7-8 hour; And ceaselessly splash into Cheng Zhu in the water with Ramulus Persicae, Ramulus Salicis Babylonicae, Ramulus Mori or Rumalus sophorae stirring to thick (treating that plaster is seemingly black as coating with lacquer); Take in the porcelain then, and porcelain is put into cold water, soaked seven days; Releasing fire-toxin is subsequent use.
During use, the plaster that has made is tiled on the lining cloth, sticks on the affected part then.
Clinical setting of the present invention:
Through the above hospital diagnosis of city-level, patient's 87 examples of (1) cyclomastopathy, year order is between 20 years old-50 years old; (2) patient's 21 examples of mammary gland fibroma, year order is between 18 years old-45 years old.
Cardinal symptom and sign:
(1) patient of cyclomastopathy shows mastalgia, and pain changes along with emotion and menstrual cycle and fluctuates, often before menstruation or angryly increase the weight of the menstrual onset pain relief when gloomy.
(2) patient of mammary gland fibroma is in the majority with young women; The main clinical manifestation lump in breast is not generally accompanied pain, sometimes with cyclomastopathy coexistence, the rounded or oval of adenoma; Diameter is with 1-3 centimetre; Strong but pliable in texture, clear border and skin surrounding tissue do not have adhesion, and its size does not generally change with menstrual cycle.Primary disease is generally one-sided, and primary disease must clear and definite and breast carcinoma " Differential Diagnosis ".
Medication and curative effect:
(1) patient's 87 examples of cyclomastopathy, subsides in per two days, 10 days is a course of treatment, the 79 routine patient symptoms recovery from illness that all disappears after three courses of treatment, 8 routine patient's symptoms are obviously improved.
(2) patient's 21 examples of mammary gland fibroma, subsides in per two days, 10 days is a course of treatment, and 18 routine patient's symptoms obviously alleviate after three courses of treatment, and 3 routine patients are invalid.
In sum, the present invention treats cyclomastopathy patient totally 108 examples, obvious effective rate 97.2%, and wherein cure rate is 83.6%.
Claims (10)
1. plaster of treating cyclomastopathy is characterized in that it being that raw material by the following weight share is processed: Radix Astragali 4-8; Rhizoma Atractylodis Macrocephalae 1-5; Spina Gleditsiae 1-5; Rhizoma Pinelliae 1-5; Cortex Magnoliae Officinalis 1-6; Radix Angelicae Sinensis 1-5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 1-5; Rhizoma Cyperi 1-5; Radix Aucklandiae 1-5; Radix Rehmanniae 1-5; Radix Et Rhizoma Rhei 1-5; Radix Salviae Miltiorrhizae 1-5; Fructus Aurantii 1-5; Radix Glycyrrhizae 1-5 and true yellow Oleum Glycines 400-600 are with to decide powder an amount of.
2. the plaster of treatment cyclomastopathy as claimed in claim 1 is characterized in that it being that raw material by the following weight share is processed: Radix Astragali 4-4.5; Rhizoma Atractylodis Macrocephalae 1-1.5; Spina Gleditsiae 1-1.5; Rhizoma Pinelliae 1-1.5; Cortex Magnoliae Officinalis 1-1.5; Radix Angelicae Sinensis 1-1.5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 1-1.5; Rhizoma Cyperi 1-1.5; Radix Aucklandiae 1-1.5; Radix Rehmanniae 1-1.5; Radix Et Rhizoma Rhei 1-1.5; Radix Salviae Miltiorrhizae 1-1.5; Fructus Aurantii 1-1.5; Radix Glycyrrhizae 1-1.5 and true yellow Oleum Glycines 400 is with to decide powder an amount of.
3. the plaster of treatment cyclomastopathy as claimed in claim 1 is characterized in that it being that raw material by the following weight share is processed: Radix Astragali 4.5-5; Rhizoma Atractylodis Macrocephalae 1.5-2; Spina Gleditsiae 1.5-2; Rhizoma Pinelliae 1.5-2; Cortex Magnoliae Officinalis 1.5-2; Radix Angelicae Sinensis 1.5-2; Cortex cinnamomi japonici (Ramulus Cinnamomi) 1.5-2; Rhizoma Cyperi 1.5-2; Radix Aucklandiae 1.5-2; Radix Rehmanniae 1.5-2; Radix Et Rhizoma Rhei 1.5-2; Radix Salviae Miltiorrhizae 1.5-2; Fructus Aurantii 1.5-2; Radix Glycyrrhizae 1.5-2 and true yellow Oleum Glycines 500 is with to decide powder an amount of.
4. the plaster of treatment cyclomastopathy as claimed in claim 1 is characterized in that it being that raw material by the following weight share is processed: Radix Astragali 5-5.5; Rhizoma Atractylodis Macrocephalae 2-2.5; Spina Gleditsiae 2-2.5; Rhizoma Pinelliae 2-2.5; Cortex Magnoliae Officinalis 2-2.5; Radix Angelicae Sinensis 2-2.5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 2-2.5; Rhizoma Cyperi 2-2.5; Radix Aucklandiae 2-2.5; Radix Rehmanniae 2-2.5; Radix Et Rhizoma Rhei 2-2.5; Radix Salviae Miltiorrhizae 2-2.5; Fructus Aurantii 2-2.5; Radix Glycyrrhizae 2-2.5 and true yellow Oleum Glycines 500 is with to decide powder an amount of.
5. the plaster of treatment cyclomastopathy as claimed in claim 1 is characterized in that it being that raw material by the following weight share is processed: Radix Astragali 5.5-6; Rhizoma Atractylodis Macrocephalae 2.5-3; Spina Gleditsiae 2.5-3; Rhizoma Pinelliae 2.5-3; Cortex Magnoliae Officinalis 2.5-3; Radix Angelicae Sinensis 2.5-3; Cortex cinnamomi japonici (Ramulus Cinnamomi) 2.5-3; Rhizoma Cyperi 2.5-3; Radix Aucklandiae 2.5-3; Radix Rehmanniae 2.5-3; Radix Et Rhizoma Rhei 2.5-3; Radix Salviae Miltiorrhizae 2.5-3; Fructus Aurantii 2.5-3; Radix Glycyrrhizae 2.5-3 and true yellow Oleum Glycines 500 is with to decide powder an amount of.
6. the plaster of treatment cyclomastopathy as claimed in claim 1 is characterized in that it being that raw material by the following weight share is processed: Radix Astragali 6-6.5; Rhizoma Atractylodis Macrocephalae 3-3.5; Spina Gleditsiae 3-3.5; Rhizoma Pinelliae 3-3.5; Cortex Magnoliae Officinalis 3-3.5; Radix Angelicae Sinensis 3-3.5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 3-3.5; Rhizoma Cyperi 3-3.5; Radix Aucklandiae 3-3.5; Radix Rehmanniae 3-3.5; Radix Et Rhizoma Rhei 3-3.5; Radix Salviae Miltiorrhizae 3-3.5; Fructus Aurantii 3-3.5; Radix Glycyrrhizae 3-3.5 and true yellow Oleum Glycines 550 is with to decide powder an amount of.
7. the plaster of treatment cyclomastopathy as claimed in claim 1 is characterized in that it being that raw material by the following weight share is processed: Radix Astragali 6.5-7; Rhizoma Atractylodis Macrocephalae 3.5-4; Spina Gleditsiae 3.5-4; Rhizoma Pinelliae 3.5-4; Cortex Magnoliae Officinalis 3.5-4; Radix Angelicae Sinensis 3.5-4; Cortex cinnamomi japonici (Ramulus Cinnamomi) 3.5-4; Rhizoma Cyperi 3.5-4; Radix Aucklandiae 3.5-4; Radix Rehmanniae 3.5-4; Radix Et Rhizoma Rhei 3.5-4; Radix Salviae Miltiorrhizae 3.5-4; Fructus Aurantii 3.5-4; Radix Glycyrrhizae 3.5-4 and true yellow Oleum Glycines 550 is with to decide powder an amount of.
8. the plaster of treatment cyclomastopathy as claimed in claim 1 is characterized in that it being that raw material by the following weight share is processed: Radix Astragali 7-8; Rhizoma Atractylodis Macrocephalae 4-5; Spina Gleditsiae 4-5; Rhizoma Pinelliae 4-5; Cortex Magnoliae Officinalis 4-5; Radix Angelicae Sinensis 4-5; Cortex cinnamomi japonici (Ramulus Cinnamomi) 4-5; Rhizoma Cyperi 4-5; Radix Aucklandiae 4-5; Radix Rehmanniae 4-5; Radix Et Rhizoma Rhei 4-5; Radix Salviae Miltiorrhizae 4-5; Fructus Aurantii 4-5; Radix Glycyrrhizae 4-5 and true yellow Oleum Glycines 600 is with to decide powder an amount of.
9. the plaster of treatment cyclomastopathy as claimed in claim 1 is characterized in that it being to be processed by following raw material medicaments: get Radix Astragali 30g; Each 15g of the Rhizoma Atractylodis Macrocephalae, Spina Gleditsiae, the Rhizoma Pinelliae, Cortex Magnoliae Officinalis, Radix Angelicae Sinensis, Cortex cinnamomi japonici (Ramulus Cinnamomi), Rhizoma Cyperi, the Radix Aucklandiae, Radix Rehmanniae, Radix Et Rhizoma Rhei, Radix Salviae Miltiorrhizae, Fructus Aurantii and Radix Glycyrrhizae; True yellow Oleum Glycines 2500g is with to decide powder an amount of.
10. make like claim 1 or 2 or 3 or 4 or 5 or 6 or 7 or the plaster of 8 or 9 described treatment cyclomastopathy, its manufacture method is described below:
To make as follows by the Chinese medicine of above-mentioned weight proportion: with true yellow Oleum Glycines medicine is soaked in the oil, soak time is 5 days springs, 3 days summers, 5 days autumns, 10 days winters; Wait to soak day full after, put it in the black earth pot, slow fire endures that to make medicine withered, floats to medicine; Filter gruffs with the sterilization calico then, make medicine oil, to going into to decide powder 500g, promptly medicine oil is 2:1 with the ratio of deciding powder with the every 1000g of medicine oil; The slow fire of useing force boils 7-8 hour, and ceaselessly stirs to thick with Ramulus Persicae, Ramulus Salicis Babylonicae, Ramulus Mori or Rumalus sophorae, splashes into Cheng Zhu in the water, takes in then in the porcelain; And porcelain put into cold water, and soaking seven days, releasing fire-toxin is subsequent use.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101383563A CN101810745B (en) | 2010-04-02 | 2010-04-02 | Plaster for treating hyperplasia of mammary glands |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101383563A CN101810745B (en) | 2010-04-02 | 2010-04-02 | Plaster for treating hyperplasia of mammary glands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101810745A CN101810745A (en) | 2010-08-25 |
| CN101810745B true CN101810745B (en) | 2012-01-25 |
Family
ID=42618205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101383563A Expired - Fee Related CN101810745B (en) | 2010-04-02 | 2010-04-02 | Plaster for treating hyperplasia of mammary glands |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101810745B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106474305A (en) * | 2016-12-02 | 2017-03-08 | 朱日朝 | A kind of Chinese medicine external powder for treating cyclomastopathy |
-
2010
- 2010-04-02 CN CN2010101383563A patent/CN101810745B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101810745A (en) | 2010-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103463528A (en) | Traditional Chinese medicine composition for treating chronic eczema | |
| CN102000301A (en) | Traditional Chinese medicine composite for treating mammitis and lobular hyperplasia of mammary gland and preparation method thereof | |
| CN104771666A (en) | Traditional Chinese medicine composition for treating psoriasis | |
| CN103071028A (en) | Traditional Chinese medicinal composition for treating anaphylactoid purpura | |
| CN103272096A (en) | Traditional Chinese medicine for treating dysmenorrhea | |
| CN102512632A (en) | Chinese herbal composition for treating abnormal menstruation | |
| CN101987138A (en) | Chinese medicinal preparation for treating impotence | |
| CN101693101A (en) | Lanceolata radish seed decoction for treating chronic gastritis | |
| CN102048899A (en) | Traditional Chinese medicine preparation for treating impotence | |
| CN103316298A (en) | Traditional Chinese composition for treating arthralgia | |
| CN103623385B (en) | A kind of Chinese medicine for the treatment of oral ulcer | |
| CN103211980A (en) | Traditional Chinese medicine composition for treatment of yin deficiency and yang excess | |
| CN102302622A (en) | Traditional Chinese medicine used for treating radiodermatitis | |
| CN102895610A (en) | Medicine for treating edema | |
| CN101810745B (en) | Plaster for treating hyperplasia of mammary glands | |
| CN103893521A (en) | Traditional Chinese medicine for treating chronic gastritis and preparation method thereof | |
| CN103768306A (en) | Traditional Chinese medicinal composition for preventing and treating asthma and preparation method thereof | |
| CN102988650A (en) | Medicament for treating chronic nephritis and preparation method of medicament | |
| CN103495103B (en) | Medicament for promoting digestion and strengthening spleen | |
| CN101658652A (en) | Chinese medicinal preparation for treating chronic appendicitis | |
| CN104042839A (en) | Traditional Chinese medicine composition for treating tinea versicolor | |
| CN105233208A (en) | Traditional Chinese medicine preparation for treating heart failure | |
| CN102145139A (en) | Traditional Chinese medicinal composition for treating fissured tongues | |
| CN103432544B (en) | Decoction for treating upper gastrointestinal hemorrhage | |
| CN103372137A (en) | Traditional Chinese medicine preparation for treating lung tumor and lung cancer of human body |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120125 Termination date: 20170402 |